Herder

Sweden
|
2018-2023
  • Adults (18-64 years)
  • People at high risk of STIs
  • Men who have sex with men
  • PrEP users
  • Non-hospital health centre
  • STD/STI clinic
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Treponema pallidum
  • Sexually transmitted infection
  • Syphilis
  • Chlamydia
  • Gonorrhea

Urban

Austria
|
2020-2023
  • Adults (18-64 years)
  • People at high risk of STIs
  • Men who have sex with men
  • PrEP users
  • Hospital
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Treponema pallidum
  • HIV
  • Hepatitis B
  • Hepatitis C
  • Sexually transmitted infection
  • Syphilis
  • Chlamydia
  • Gonorrhea
  • HIV

M-BOOST-FR

France
|
2025-2027
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • People at high risk of STIs
  • Men who have sex with men
  • PrEP users
  • Outpatient clinic
  • Monkeypox virus
  • Mpox
  • Sexually transmitted infection
  • Serum
  • Pharmacological intervention
  • Vaccination
  • MVA-BN

SeVIHPrEP

Spain
|
2020-2030
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • People at high risk of STIs
  • Men who have sex with men
  • PrEP users
  • Non-hospital health centre
  • STD/STI clinic
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Treponema pallidum
  • HIV
  • Mycoplasma genitalium
  • Hepatitis
  • Sexually transmitted infection
  • Anal-rectal swab
  • Oral swab
  • Urethral exudate
  • Pharmacological intervention
  • PrEP-HIV

DanPrEPD

Denmark
|
2022-2022
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • People at high risk of STIs
  • Men who have sex with men
  • PrEP users
  • Primary care
  • Non-hospital health centre
  • STD/STI clinic
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Treponema pallidum
  • Sexually transmitted infection
  • Syphilis
  • Pharmacological intervention
  • Antivirals
  • PrEP-HIV

SwissPrEPared

Switzerland
|
2019-2022
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • People at high risk of STIs
  • PrEP users
  • Hospital
  • Community
  • Primary care
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Treponema pallidum
  • Sexually transmitted infection
  • Syphilis
  • Pharmacological intervention
  • PrEP-bSTI

STD-MAR/Mpox

Spain
|
2023
  • Adults (18-64 years)
  • People at high risk of STIs
  • PrEP users
  • People living with HIV
  • Hospital
  • Outpatient clinic
  • Monkeypox virus
  • Mpox
  • Blood sample
  • Pharmacological intervention
  • Vaccination
  • JYNNEOS

MonVIP

France
|
2023
  • Adults (18-64 years)
  • Fragile population
  • People at high risk of STIs
  • Immunocompromised host
  • PrEP users
  • People living with HIV
  • Hospital
  • Outpatient clinic
  • Infectious diseases unit
  • Monkeypox virus
  • Mpox

PISCIS

Spain
|
2022-2022
  • Adults (18-64 years)
  • Fragile population
  • People at high risk of STIs
  • Immunocompromised host
  • PrEP users
  • People living with HIV
  • Non-hospital health centre
  • Telemedicine
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Vaccination

MASH-1

United Kingdom France Spain Poland
|
2024-2024
  • Adults (18-64 years)
  • Fragile population
  • People at high risk of STIs
  • Immunocompromised host
  • PrEP users
  • People living with HIV
  • Outpatient clinic
  • Non-hospital health centre
  • STD/STI clinic
  • Monkeypox virus
  • Mpox

Fontàn-Vela

Spain
|
2022-2022
  • Adults (18-64 years)
  • General population
  • People at high risk of STIs
  • PrEP users
  • Hospital
  • Outpatient clinic
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Vaccination
  • MVA-BN

Mpox-Cohort

Italy
|
2022-2022
  • Adults (18-64 years)
  • Fragile population
  • PrEP users
  • People living with HIV
  • Hospital
  • Outpatient clinic
  • Infectious diseases unit
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Vaccination
  • MVA-BN